Swiss contract drug manufacturer Lonza's plants in the United States and Switzerland are due to make ingredients for 400 million doses of Moderna's COVID-19 vaccine annually, Lonza said on Monday.
Discover how slalom chromatography is revolutionizing biomolecule analysis with Dr. Fabrice Gritti and host Neil Lander on Chromatography Life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback